Dicerna Pharmaceuticals

-$0.04 (-0.11%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRNA and other ETFs, options, and stocks.

About DRNA

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas.

CEO

Douglas M. Fambrough

Employees

302

Headquarters

Lexington, Massachusetts

Founded

2006

DRNA Key Statistics

Market Cap

2.84B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

662.36K

High Today

$37.29

Low Today

$35.89

Open Price

$37.01

Volume

499.45K

52 Week High

$40.14

52 Week Low

$16.50

DRNA News

Simply Wall St23h

Did Dicerna Pharmaceuticals, Inc. Insiders Buy Up More Shares?

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales ha

Analyst Ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

DRNA Earnings

-$0.58

-$0.20

$0.17

$0.55

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 9, Pre-Market